338 related articles for article (PubMed ID: 30212538)
1. Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.
Lee HJ; Lee H; Oh SH; Park J; Park S; Jeon JS; Noh H; Han DC; Kwon SH
PLoS One; 2018; 13(9):e0203878. PubMed ID: 30212538
[TBL] [Abstract][Full Text] [Related]
2. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
Liabeuf S; Lambert O; Metzger M; Hamroun A; Laville M; Laville SM; Frimat L; Pecoits-Filho R; Fouque D; Massy ZA; Jacquelinet C; Stengel B;
Br J Clin Pharmacol; 2021 Jul; 87(7):2967-2976. PubMed ID: 33368448
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis.
Grant CH; Gillis KA; Lees JS; Traynor JP; Mark PB; Stevens KI
QJM; 2019 Nov; 112(11):835-840. PubMed ID: 31251364
[TBL] [Abstract][Full Text] [Related]
5. Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.
Klatte DCF; Gasparini A; Xu H; de Deco P; Trevisan M; Johansson ALV; Wettermark B; Ärnlöv J; Janmaat CJ; Lindholm B; Dekker FW; Coresh J; Grams ME; Carrero JJ
Gastroenterology; 2017 Sep; 153(3):702-710. PubMed ID: 28583827
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
Hart E; Dunn TE; Feuerstein S; Jacobs DM
Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
[TBL] [Abstract][Full Text] [Related]
7. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children: An Analysis of the CURE-CKD Registry.
Tuttle KR; Alicic RZ; Duru OK; Jones CR; Daratha KB; Nicholas SB; McPherson SM; Neumiller JJ; Bell DS; Mangione CM; Norris KC
JAMA Netw Open; 2019 Dec; 2(12):e1918169. PubMed ID: 31860111
[TBL] [Abstract][Full Text] [Related]
9. Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort.
Rodríguez-Poncelas A; Barceló MA; Saez M; Coll-de-Tuero G
PLoS One; 2018; 13(10):e0204231. PubMed ID: 30332411
[TBL] [Abstract][Full Text] [Related]
10. Non-indicated initiation of proton pump inhibitor and risk of adverse outcomes in patients with underlying chronic kidney disease: a nationwide, retrospective, cohort study.
Kim SG; Cho JM; Han K; Joo KW; Lee S; Kim Y; Cho S; Huh H; Kim M; Kang E; Kim DK; Park S
BMJ Open; 2024 Jan; 14(1):e078032. PubMed ID: 38286693
[TBL] [Abstract][Full Text] [Related]
11. [Impact of an evaluation of the professional practices on the relevance of proton pump inhibitors prescriptions pertinence at the hospital].
Daumas A; Garros E; Mendizabal H; Gayet S; Bernard F; Bagnères D; Demoux AL; Rossi P; Villani P; Granel B
Rev Med Interne; 2018 Aug; 39(8):618-626. PubMed ID: 29628172
[TBL] [Abstract][Full Text] [Related]
12. Effect of low-dose proton pump inhibitor on preventing upper gastrointestinal bleeding in chronic kidney disease patients receiving aspirin.
Lim H; Kim JH; Baik GH; Park JW; Kang HS; Moon SH; Park CK
J Gastroenterol Hepatol; 2015 Mar; 30(3):478-84. PubMed ID: 25252119
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
Xie Y; Bowe B; Li T; Xian H; Balasubramanian S; Al-Aly Z
J Am Soc Nephrol; 2016 Oct; 27(10):3153-3163. PubMed ID: 27080976
[TBL] [Abstract][Full Text] [Related]
14. Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice?
Al-Qaisi MT; Kahn A; Crowell MD; Burdick GE; Vela MF; Ramirez FC
Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29873678
[TBL] [Abstract][Full Text] [Related]
15. The CKD Outcomes and Practice Patterns Study (CKDopps): Rationale and Methods.
Mariani L; Stengel B; Combe C; Massy ZA; Reichel H; Fliser D; Pecoits-Filho R; Lopes AA; Yamagata K; Wada T; Wong MM; Speyer E; Port FK; Pisoni RL; Robinson BM
Am J Kidney Dis; 2016 Sep; 68(3):402-13. PubMed ID: 27113505
[TBL] [Abstract][Full Text] [Related]
16. The use of anti-ulcer agents and the risk of chronic kidney disease: a meta-analysis.
Sun J; Sun H; Cui M; Sun Z; Li W; Wei J; Zhou S
Int Urol Nephrol; 2018 Oct; 50(10):1835-1843. PubMed ID: 29948864
[TBL] [Abstract][Full Text] [Related]
17. Demographic and health-related predictors of proton pump inhibitor (PPI) use and association with chronic kidney disease (CKD) stage in NHANES population.
Devraj R; Deshpande M
Res Social Adm Pharm; 2020 Jun; 16(6):776-782. PubMed ID: 31445985
[TBL] [Abstract][Full Text] [Related]
18. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
Lundström UH; Gasparini A; Bellocco R; Qureshi AR; Carrero JJ; Evans M
BMC Nephrol; 2017 Feb; 18(1):59. PubMed ID: 28187786
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs.
Lamine F; Lalubin F; Pitteloud N; Burnier M; Zanchi A
Swiss Med Wkly; 2016; 146():w14282. PubMed ID: 26922155
[TBL] [Abstract][Full Text] [Related]
20. Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy.
Lodato F; Poluzzi E; Raschi E; Piccinni C; Koci A; Olivelli V; Napoli C; Corvalli G; Nalon E; De Ponti F; Zoli M
Eur J Intern Med; 2016 May; 30():31-36. PubMed ID: 26926561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]